Antibe Therapeutics to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference
TORONTO, April 25, 2022--(BUSINESS WIRE)--Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapie...